BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 36775306)

  • 1. "Quadruple-hit" primary testicular diffuse large B-cell lymphoma with MYD88 L265P mutation, IGH::MYC, and IRF4- and BCL6-rearrangements.
    Bruehl FK; Ketterling RP; Rimsza LM; Santos EF; McPhail ED
    J Hematop; 2023 Sep; 16(3):161-165. PubMed ID: 38175404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma.
    Zhang F; Chen Y; Cui Q; Ge Y; Liu Y
    Discov Oncol; 2024 Apr; 15(1):129. PubMed ID: 38662249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toripalimab plus lenalidomide for central nervous system recurrence in refractory CD5
    Chen X; Zhang Z; Zhang J; Yu Q; Qiu J; Xiao Y; Chen B; Xu P
    Transl Cancer Res; 2024 Feb; 13(2):1188-1195. PubMed ID: 38482415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rare Case of Ovarian Double-Hit/Diffuse Large B-Cell Lymphoma: A Case Report and Review of Literature.
    Urella M; Nwanwene K; Sidda A; Pacioles T
    J Investig Med High Impact Case Rep; 2023; 11():23247096231154641. PubMed ID: 36840472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
    Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
    BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma.
    Win KT; Hsieh YC; Wu HC; Chuang SS
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of diffuse large B-cell lymphoma with decompensated alcohol-related liver cirrhosis treated successfully by chemoimmunotherapy.
    Li Y; Kong LZ
    Clin Case Rep; 2024 Apr; 12(4):e8820. PubMed ID: 38659497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffuse large B-cell lymphoma with DNA copy number changes in a Japanese black calf.
    Maezawa M; Watanabe KI; Kobayashi Y; Yoshida K; Chambers JK; Uchida K; Maruyama R; Inokuma H
    Vet Res Commun; 2024 Apr; ():. PubMed ID: 38575802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare case of dual expression of CD5 and CD10 in primary central nervous system diffuse large B-cell lymphoma with prominent starry sky appearance.
    McCorkle C; Graffeo V
    Clin Case Rep; 2020 Dec; 8(12):2973-2975. PubMed ID: 33363862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigmoid Colon Perforation in Diffuse Large B-Cell Lymphoma Due to Tacrolimus-Induced Immunodeficiency: A Case Report.
    Sakuraba S; Nakamura K; Koido K; Hazama H; Ohata K
    Cureus; 2024 Feb; 16(2):e54571. PubMed ID: 38516454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers.
    Fan J; Thanedar S; Ovechko V; Jana B
    Case Rep Oncol; 2024; 17(1):517-523. PubMed ID: 38549625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse large B-cell lymphoma presenting with cavitary lung disease.
    Hibino Y; Imai R; Jinta T
    Respirol Case Rep; 2020 Jul; 8(5):e00584. PubMed ID: 32405417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of
    Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
    Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
    [No Abstract]   [Full Text] [Related]  

  • 15. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
    Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
    Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse large B cell lymphoma CD5-positive arising in an immune deficiency and immune dysregulation setting: A case report and brief review of the literature.
    Cristian M; Baz RA; Stoica AG; Așchie M; Ghinea MM; Deacu M; Boșoteanu M; Mitroi AF; Dobrin N; Iordache IE; Bălțătescu GI
    Medicine (Baltimore); 2023 Feb; 102(8):e33083. PubMed ID: 36827036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CD5- and CD10-positive MYC and BCL2 double-expressor diffuse large B-cell lymphoma with MYD88
    Sasaki Y; Murai S; Okamura R; Uesugi Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Yanagisawa K; Honma M; Yamochi T; Hattori N
    Rinsho Ketsueki; 2023; 64(1):42-48. PubMed ID: 36775306
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.